Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Degarelix
Locations
3
Canada
London Regional Cancer Centre
London, Ontario, Canada
Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Princess Margeret Hospital
Toronto, Ontario, Canada
Start Date
May 1, 2011
Primary Completion Date
October 1, 2011
Completion Date
July 1, 2013
Last Updated
May 7, 2020
NCT07225946
NCT04868604
NCT00756665
NCT05743621
NCT04104776
NCT06242119
Lead Sponsor
Ottawa Hospital Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions